Similarly, SHK-loaded and hyaluronic acid-modified mesoporous polydopamine (MPDA) nanoparticles reprogram CRC metabolism by targeting PKM2, reversing EMT, and suppressing colorectal liver metastasis (88). This evidence concerns the gene PKM and colorectal carcinoma.